Stratagene to face PCR patent suit:
This article was originally published in Clinica
Executive Summary
Applera has filed suit against research and immunodiagnostic tools manufacturer Stratagene for alleged infringement of its '934 patent. The products involved in the dispute are instruments used to perform real-time PCR. La Jolla, California-based Stratagene is already licensed to manufacture, use and sell PCR thermal cyclers originally developed by Applied BioSystems, one of Applera's two main business groups.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.